New Test May Help Breast Cancer Patients At ‘Ultralow’ Death Risk

June 30, 2017 | By admin

A new test may help to identify breast cancer patients with the lowest risk of death, therefore helping them to avoid unnecessarily aggressive treatment.  Researchers from the University of California, San Francisco (UCSF) – in collaboration with scientists from various universities across Sweden – have found that a molecular test can help to predict which breast cancer patients will have the lowest risk of death.  The lead author of the study is Dr. Laura J. Esserman, a breast cancer specialist and surgeon with UCHealth. The findings were published in the journal JAMA Oncology.